Montelukast Sodium Tablets, 10 mg*, 30-count bottles, Rx Only, By: Hetero, Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, NDC 31722-726-30.
Published October 3, 2018 · Recall initiated: August 20, 2018
Summary
FDA records drug Class II recall D-1213-2018, published October 3, 2018 and initiated August 20, 2018. Recalling firm: Hetero Labs Limited Unit V; Status: Terminated; Reported quantity: 98,016 bottles; Lot: Lot #: MON17355, Exp 12/19. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Discoloration: A complaint was received from a pharmacist for the presence of blue specks on tablets.
What to do
Voluntary: Firm initiated · Letter
Get an email if MONTELUKAST SODIUM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- MONTELUKAST SODIUM
- Manufacturer
- Hetero Labs Limited Unit V
- Distributor
- Nationwide in the USA
- UPC
- 0331722726306
- Lot
- Lot #: MON17355, Exp 12/19
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDAMontelukast Sodium Tablets, USP 10 mg, Rx Only, 1000 count bottle, Distributed by: Dr. Reddy's Laboratories.,November 15, 2023
- FDAMontelukast Sodium Tablets, USP, 10 mg* Rx Only, Packaged as: a) 30-count bottle NDC 16729-119-10 UPC 3 16729March 8, 2023
- FDAMontelukast Sodium Chewable Tablets, 5 mg, 90-count bottles, Rx Only, Manufactured for : Macleods Pharma USA,February 5, 2020
- FDAMontelukast Sodium Tablets 10 mg, 30-count bottle, Rx Only, By: Hetero Hetero Labs Limited, Unit V, Polepally,October 3, 2018
- FDAFenofibrate Tablets, USP 145 mg, 90-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc.October 3, 2018
- FDALevofloxacin Injection in 5% Dextrose, 5 mg/mL, packaged in a) 50 mL (NDC 36000-046-24), b) 100 mL (NDCOctober 3, 2018
Questions about this recall
Was Montelukast Sodium Tablets, 10 mg*, 30-count bottles, Rx Only, By: Hetero, Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, NDC 31722-726-30. recalled?
Yes. FDA published recall D-1213-2018 on October 3, 2018. Reported hazard: Discoloration: A complaint was received from a pharmacist for the presence of blue specks on tablets.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: MONTELUKAST SODIUM. UPC: 0331722726306.